Endogenous CD4(+) T cells recognize neoantigens in lung cancer patients, including recurrent oncogenic KRAS and ERBB2 (Her2) driver mutations

T cells specific for neoantigens encoded by mutated genes in cancers are increasingly recognized as mediators of tumor destruction after immune checkpoint inhibitor therapy or adoptive cell transfer. Much of the focus has been on identifying epitopes presented to CD8(+) T cells by class I MHC. Howev...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Immunol Res
Hoofdauteurs: Veatch, Joshua R., Jesernig, Brenda L., Kargl, Julia, Fitzgibbon, Matthew, Lee, Sylvia M., Baik, Christina, Martins, Renato, Houghton, A. McGarry, Riddell, Stanley R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6584616/
https://ncbi.nlm.nih.gov/pubmed/31043415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0402
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items